StockTipsArenaBeta

IPCA Laboratories LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹1,959.1-6.20 (-0.32%)
Analysts lean BUY·all 2 long-term calls are BUY·consensus 1Y target ₹2,042.5 (4.3% above CMP)
₹2,042.5
4.3% above CMP
₹2,025 – ₹2,060
2 active 1Y targets
7 open
7 BUY · 0 SELL (all horizons)
63%
15 of 24 closed calls hit
Watch IPCALAB for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (32) · loading…

BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)
AI15+·1−+8.5% P&L+3.4% upside left
₹1,959.1
CMP
Entry*
₹1,805.9
Target
₹2,025
NWNuvama Wealth· via ET Now (Live)3w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)
AI15+·1−+13.0% P&L+5.2% upside left
₹1,959.1
CMP
Entry*
₹1,734.2
Target
₹2,060
MOMotilal Oswal· via Institutional / Brokerage Research3w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI16+·6−+3.47% realised0.0% upside left
Entry*
₹1,884.6
Target
₹1,950
hit 25 Aug 2026, 12:08 pm
EGEmkay Global· via Institutional / Brokerage Research3w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.39% realised0.0% upside left
Entry*
₹1,507.7
Target
₹1,800
hit 6 Jul 2026, 12:00 am
PLPrabhudas Lilladher· via Institutional / Brokerage Research13w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+19.39% realised0.0% upside left
Entry*
₹1,507.7
Target
₹1,800
hit 6 Jul 2026, 12:00 am
EGEmkay Global· via Institutional / Brokerage Research13w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.37% realised0.0% upside left
Entry*
₹1,507.7
Target
₹1,845
hit 14 Jul 2026, 12:07 pm
ISICICI Securities· via Institutional / Brokerage Research13w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.08% realised0.0% upside left
Entry*
₹1,490.4
Target
₹1,730
hit 30 Jun 2026, 12:06 pm
MOMotilal Oswal· via Institutional / Brokerage Research14w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+16.27% realised0.0% upside left
Entry*
₹1,565.3
Target
₹1,820
hit 13 Jul 2026, 12:07 pm
MOMotilal Oswal· via Institutional / Brokerage Research24w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.47% realised0.0% upside left
Entry*
₹1,494.2
Target
₹1,800
hit 6 Jul 2026, 12:00 am
PLPrabhudas Lilladher· via Institutional / Brokerage Research26w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+14.64% realised0.0% upside left
Entry*
₹1,491.6
Target
₹1,710
hit 30 Jun 2026, 12:06 pm
PLPrabhudas Lilladher· via Institutional / Brokerage Research28w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+20.68% realised0.0% upside left
Entry*
₹1,491.6
Target
₹1,800
hit 6 Jul 2026, 12:00 am
ISICICI Securities· via Institutional / Brokerage Research28w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+15.04% realised0.0% upside left
Entry*
₹1,495.1
Target
₹1,720
hit 30 Jun 2026, 12:06 pm
MOMotilal Oswal· via Institutional / Brokerage Research29w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+13.33% realised0.0% upside left
Entry*
₹1,464.8
Target
₹1,660
hit 19 May 2026, 12:05 pm
ISICICI Securities· via Institutional / Brokerage Research42w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+22.89% realised0.0% upside left
Entry*
₹1,302
Target
₹1,600
hit 17 Mar 2026, 12:03 pm
MOMotilal Oswal· via Institutional / Brokerage Research42w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+15.75% realised0.0% upside left
Entry*
₹1,498.1
Target
₹1,734
hit 2 Jan 2025, 12:01 pm
SRSharekhan Research· via Institutional / Brokerage Research101w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+18.60% realised0.0% upside left
Entry*
₹1,349.05
Target
₹1,600
hit 9 Oct 2024, 12:10 pm
SRSharekhan Research· via Institutional / Brokerage Research107w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-11.81% realisedNA upside left
₹1,439.8
At expiry
Entry*
₹1,632.65
Target
₹1,980
expired 26 Dec 2025, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research88w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-3.71% realisedNA upside left
₹1,479.6
At expiry
Entry*
₹1,536.55
Target
₹1,765
expired 14 Nov 2025, 3:30 pm
SRSharekhan Research· via Institutional / Brokerage Research94w ago
BUYIPCALABIPCA Laboratories1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-22.36% realisedNA upside left
₹1,306.1
At expiry
Entry*
₹1,682.2
Target
₹1,950
expired 14 Oct 2025, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research99w ago
BUYIPCALABIPCA Laboratories1–3 Months
AI16+·2−+4.0% P&L+9.7% upside left
₹1,959.1
CMP
SL
₹1,700
Entry*
₹1,882.9
Target
₹2,150
VSVikas Sethi, Sethi Finmart· via Zee Business (Live)2w ago
BUYIPCALABIPCA Laboratories1–3 Months
AI16+·2−+3.7% P&L+9.7% upside left
₹1,959.1
CMP
SL
₹1,790
Entry
₹1,890
Target
₹2,150
RVRaja Venkatraman· via LiveMint Markets2w ago
BUYIPCALABIPCA Laboratories1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI16+·2−+9.3% P&L0.0% upside left
₹1,959.1
CMP
SL
₹1,720
Entry
₹1,792
Target
₹1,945
ICIDBI Capital· via IDBI Capital Research Calls Telegram8w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI5+·1−-0.8% P&L+3.9% upside left
₹1,959.1
CMP
SL
₹1,945
Entry
₹1,975
Target
₹2,035
ICIDBI Capital· via IDBI Capital Research Calls Telegram8h ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI5+·1−-0.3% P&L+9.7% upside left
₹1,959.1
CMP
Entry*
₹1,965.4
Target
₹2,150
PGPrakash Gaba· via CNBC Awaaz.10h ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·6−+4.36% realised0.0% upside left
SL
₹1,751
Entry
₹1,790
Target
₹1,868
hit 13 Aug 2026, 1:35 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram3w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI4+·6−-3.04% realisedNA upside left
SL
₹1,850
Entry*
₹1,908.1
Target
₹2,000
hit 17 Aug 2026, 10:00 am
MJManas Jaiswal· via CNBC Awaaz.3w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI2+·1−-3.68% realisedNA upside left
SL
₹1,700
Entry
₹1,765
Target
₹1,890
hit 10 Aug 2026, 10:00 am
SBSumeet Bagadia, Choice Broking· via LiveMint Buy-or-Sell (topic)4w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-3.04% realisedNA upside left
SL
₹1,595
Entry
₹1,645
Target
₹1,795
hit 12 Jun 2026, 1:20 pm
MBMadhu Bansal· via CNBC Awaaz.12w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-2.29% realisedNA upside left
SL
₹1,580
Entry
₹1,617
Target
₹1,685
hit 25 May 2026, 12:55 pm
KBKunal Bothra· via ET Now16w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI15+·2−+1.81% realisedNA upside left
₹1,958.9
At expiry
Entry*
₹1,924
Target
₹2,000
expired 7 Sept 2026, 3:30 pm
SSSudeep Shah, SBICAP Securities· via Zee Business (Live)1w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI14+·2−+3.01% realisedNA upside left
₹1,957.3
At expiry
SL
₹1,850
Entry*
₹1,900.1
Target
₹2,030
expired 3 Sept 2026, 3:30 pm
KBKush Bohra· via NDTV Profit (Live)2w ago
BUYIPCALABIPCA Laboratories1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired○ No trade
— realisedNA upside left
SL
₹1,600
Entry
₹1,680
Target
₹1,720
KBKush Bohra· via NDTV Profit15w ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.